| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/19/2005 | EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia |
| 10/19/2005 | EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use |
| 10/19/2005 | EP1586587A1 Compositions and methods for detecting angiogenesis |
| 10/19/2005 | EP1586586A2 Peptide and/or proteins and their use for the manufacture of a therapeutic and/or preventive medicament |
| 10/19/2005 | EP1586585A1 Expression system for the production of IL-15/Fc fusion proteins and their use |
| 10/19/2005 | EP1586584A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
| 10/19/2005 | EP1586583A2 Compounds that block C5a complement receptor and their use in therapy |
| 10/19/2005 | EP1586582A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 10/19/2005 | EP1586331A1 Development of a preventive vaccine for filovirus infection in primates |
| 10/19/2005 | EP1586329A1 Botulinum toxin pharmaceutical compositions |
| 10/19/2005 | EP1586324A1 Ophthalmic therapeutic composition |
| 10/19/2005 | EP1586235A2 Cytoplamic male sterility system producing canola hybrids |
| 10/19/2005 | EP1585985A2 Human pellino polypeptides |
| 10/19/2005 | EP1585984A2 Diagnostic methods for protein profiling |
| 10/19/2005 | EP1585966A2 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 10/19/2005 | EP1585960A2 Mucin immobilized chromatography |
| 10/19/2005 | EP1585959A2 Extended glucagon-like peptide-1 analogs |
| 10/19/2005 | EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 10/19/2005 | EP1585954A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 10/19/2005 | EP1585819A2 Mixing and matching tc proteins for pest control |
| 10/19/2005 | EP1585813A1 Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 10/19/2005 | EP1585765A2 Splice variant of human placental growth hormone |
| 10/19/2005 | EP1585764A2 Rantes-derived peptides with anti-hiv activity |
| 10/19/2005 | EP1585763A2 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation |
| 10/19/2005 | EP1585761A2 L-amino acid oxidase with cytotoxic activity from aplysia punctata |
| 10/19/2005 | EP1585760A2 Btl-ii nucleic acids, proteins, and antibodies |
| 10/19/2005 | EP1585759A1 Gene resistant to aphis gossypii |
| 10/19/2005 | EP1585758A1 Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated peg peptides using the same |
| 10/19/2005 | EP1585546A2 Kim-1 antagonists and use to modulate immune system |
| 10/19/2005 | EP1585543A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| 10/19/2005 | EP1585541A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 10/19/2005 | EP1585539A2 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 10/19/2005 | EP1585538A1 Modified hemoglobin and methods of making same |
| 10/19/2005 | EP1585535A2 Pthrp-derived modulators of smooth muscle proliferation |
| 10/19/2005 | EP1585484A2 Hepatocyte growth factor variants |
| 10/19/2005 | EP1585480A2 Erbb4 co-crystal |
| 10/19/2005 | EP1585391A2 Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same |
| 10/19/2005 | EP1585386A2 Transgenic production in saliva |
| 10/19/2005 | EP1585384A2 Precise breeding |
| 10/19/2005 | EP1492879A4 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
| 10/19/2005 | EP1465909A4 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof |
| 10/19/2005 | EP1438333A4 Anti-fusion assay |
| 10/19/2005 | EP1373471B1 Defined culture medium |
| 10/19/2005 | EP1353948B1 Soluble cyclic analogues of the beta amyloide peptide |
| 10/19/2005 | EP1346045B1 Human protooncogene and protein encoded therein |
| 10/19/2005 | EP1307482B1 Two coloured fluorimetric protease assay |
| 10/19/2005 | EP1294929B1 Method to detect modulators of vegf kinase domain |
| 10/19/2005 | EP1292618B1 Vip-related peptides for the treatment of sexual disorders in women |
| 10/19/2005 | EP1259251B1 Novel method for down-regulation of amyloid |
| 10/19/2005 | EP1198249B1 Use of cpg as an adjuvant for hiv vaccine |
| 10/19/2005 | EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent |
| 10/19/2005 | EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 10/19/2005 | EP1088055A4 Allelic series of genomic modifications in cells |
| 10/19/2005 | EP1049783B1 Frozen food product |
| 10/19/2005 | EP1015583B1 Protein containing an srcr domain |
| 10/19/2005 | EP1000163B1 Pseudomonas exotoxin a-like chimeric immunogens |
| 10/19/2005 | EP0882132B1 A human cytomegalovirus combined antigen and its use |
| 10/19/2005 | EP0871354B1 Hypersensitive response induced resistance in plants |
| 10/19/2005 | EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma |
| 10/19/2005 | CN1685234A Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
| 10/19/2005 | CN1685058A Peptides with anti-hypertensive properties |
| 10/19/2005 | CN1685057A Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 10/19/2005 | CN1685046A Modulating developmental pathways in plants |
| 10/19/2005 | CN1685041A Method of predicting genetic risk for hypertension |
| 10/19/2005 | CN1684980A Novel albumins |
| 10/19/2005 | CN1684979A Glycosylated human interferon alpha isoform |
| 10/19/2005 | CN1684978A Glycosylated human granulocyte colony-stimulating factor (G-CSF) isoform |
| 10/19/2005 | CN1684977A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 10/19/2005 | CN1684976A Antibacterial substance produced by lactic acid bacterium |
| 10/19/2005 | CN1684975A Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 10/19/2005 | CN1684974A Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 10/19/2005 | CN1684972A Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy |
| 10/19/2005 | CN1684941A Method for producing acylated peptides |
| 10/19/2005 | CN1684704A Interferon and immunologublin FC fragment hybrid |
| 10/19/2005 | CN1684700A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/19/2005 | CN1683526A Histone methyl transferase and its preparing method |
| 10/19/2005 | CN1683414A Process for preparing stereo arrested amine nitrogen oxygen free redical with hydrotalcite analog as catalyst |
| 10/19/2005 | CN1683408A Glucagon-like peptide analog, its composition and its using method |
| 10/19/2005 | CN1683407A Synthetic process for alkaline phosphatase marked free thyroid hormone |
| 10/19/2005 | CN1683406A Clonorichis sinensis CDC 42 like protein, its coded nucleic acid and its use |
| 10/19/2005 | CN1683405A Clonorichis sinensis II 14-3-3 protein, its coded nucleic acid and its use |
| 10/19/2005 | CN1683404A Clonorichis sinensis ubiquitin homogenetic protein, its coded nucleic acid and its use |
| 10/19/2005 | CN1683403A Japanese blood fluke cell periodic static agent, its coded nucleic acid and its use |
| 10/19/2005 | CN1683402A Clonorichis sinensis annexin, its coded nucleic acid and its use |
| 10/19/2005 | CN1683401A Clonorchis sinensis GTP bindin alpha subunit, its coded nucleic acid and its use |
| 10/19/2005 | CN1683400A Clonorchis sinensis transport protein, its coded nucleic acid and its use |
| 10/19/2005 | CN1683399A Wasp antibiotic peptide and its preparing method and use |
| 10/19/2005 | CN1683398A Plant anti reversion relative protein and its coding gene and use |
| 10/19/2005 | CN1683397A Process for extracting protein, total flavone and super oxide dismutase from sea-buckthorn fresh branch and leaf |
| 10/19/2005 | CN1683396A Polypeptide capable of inhibiting typhsid bacillus from invading human body cell and its preparing method |
| 10/19/2005 | CN1683362A Method for preparing soybean isoflavone, soybean spanin, oligosaccharide and soybean concentrated protein |
| 10/19/2005 | CN1683010A Human papillomavirus type bivalent virus-like particle mixed protein antigen and construction method |
| 10/19/2005 | CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 10/19/2005 | CN1223608C Caspase-8 interacting proteins |
| 10/19/2005 | CN1223607C Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application |
| 10/19/2005 | CN1223606C Rice DREB transcription factor and its encoding gene and use |
| 10/19/2005 | CN1223605C Polypeptide medicine for inhibiting SARS corona virus, and derivatives and use thereof |
| 10/18/2005 | US6956149 Method of conveying BNYVV resistance to sugar beet plants |
| 10/18/2005 | US6956118 Promoter sequences providing male tissue-preferred expression in plants |
| 10/18/2005 | US6956117 Highly conserved non-translated regions are mutated to give rise to RNA sequence that provides greater efficiency of transduction/replication |